Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Magen-Darm » Funktionelle Beschwerden 22. Mai 2017
Suchen
Gastroplattform
Funktionelle Beschwerden
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Diarrhoe
IBD (Crohn/Colitis)
Funktionelle Beschwerden
Gastroenteritis
GI-Blutung
Neoplasie
Peptisches Ulkus
Anderes
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 272  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 5426  
   
Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.
Intest Res
Mizukami T, Sugimoto S, Masaoka T, Suzuki H, Kanai T.
PMID: 28522955 [PubMed - in process]


Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.
World J Gastroenterol
Zhao JM, Li L, Chen L, Shi Y, Li YW, Shang HX, Wu LY, Weng ZJ, Bao CH, Wu HG.
PMID: 28522910 [PubMed - in process]


Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study.
BMC Gastroenterol
Jarbøl DE, Rasmussen S, Balasubramaniam K, Elnegaard S, Haastrup PF.
PMID: 28521729 [PubMed - in process]


The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
J Adv Pharm Technol Res
Dehkordi AH, Solati K.
PMID: 28516059 [PubMed - in process]


Differential expression of microRNAs related to irritable bowel syndrome in a rabbit model.
J Dig Dis
Yang Q, Xu X, Zhao H, Cai Y, Pan Y, Xu J, Ma Q, Chen M.
PMID: 28509372 [PubMed - as supplied by publisher]


Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.
Phytother Res
Alt F, Chong PW, Teng E, Uebelhack R.
PMID: 28508427 [PubMed - as supplied by publisher]


Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.
Drugs
Keating GM.
PMID: 28493170 [PubMed - in process]


Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: a Pilot Study in Patients With Irritable Bowel Syndrome.
Gastroenterology
Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berner B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P.
PMID: 28483500 [PubMed - as supplied by publisher]


Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial.
J Neurogastroenterol Motil
Jang A, Hwang SK, Padhye NS, Meininger JC.
PMID: 28480684 [PubMed - as supplied by publisher]


[New options in the tratment of irritable bowel syndrome].
MMW Fortschr Med
Wettstein M.
PMID: 28466312 [PubMed - in process]


The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling.
Psychol Med
Hesser H, Hedman E, Lindfors P, Andersson E, Ljótsson B.
PMID: 28464975 [PubMed - as supplied by publisher]


Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.
J Neurogastroenterol Motil
Stasi C, Bellini M, Gambaccini D, Duranti E, de Bortoli N, Fani B, Albano E, Russo S, Sudano I, Laffi G, Taddei S, Marchi S, Bruno RM.
PMID: 28460516 [PubMed - as supplied by publisher]


Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop.
Transl Gastroenterol Hepatol
McCullough R, McCullough J.
PMID: 28447053 [PubMed - in process]


Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.
Healthcare (Basel)
Ikechi R, Fischer BD, DeSipio J, Phadtare S.
PMID: 28445436 [PubMed - in process]


Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.
Aliment Pharmacol Ther
Krogsgaard LR, Lyngesen M, Bytzer P.
PMID: 28440580 [PubMed - in process]


Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
PLoS One
Kato T, Honda Y, Kurita Y, Iwasaki A, Sato T, Kessoku T, Uchiyama S, Ogawa Y, Ohkubo H, Higurashi T, Yamanaka T, Usuda H, Wada K, Nakajima A.
PMID: 28410406 [PubMed - indexed for MEDLINE]


Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Value Health
Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ, Critical Path Institute Patient-Reported Outcome Consortium.
PMID: 28408004 [PubMed - indexed for MEDLINE]


Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.
World J Gastroenterol
Flik CE, Bakker L, Laan W, van Rood YR, Smout AJ, de Wit NJ.
PMID: 28405151 [PubMed - in process]


Pathophysiology of irritable bowel syndrome.
Lancet Gastroenterol Hepatol
Holtmann GJ, Ford AC, Talley NJ.
PMID: 28404070 [PubMed - in process]


Management of the multiple symptoms of irritable bowel syndrome.
Lancet Gastroenterol Hepatol
Simrén M, Törnblom H, Palsson OS, Whitehead WE.
PMID: 28403981 [PubMed - in process]


   
   Artikel 1 - 20 / 5426    Seite 1 von 272  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1